Financhill
Back

Panbela Therapeutics Quote, Financials, Valuation and Earnings

Panbela Therapeutics Price Quote

$0.43
-0.01 (-1.22%)
(Updated: April 30, 2024 at 5:05 PM ET)

Panbela Therapeutics Key Stats

Sell
24
Panbela Therapeutics (PBLA) is a Sell

Day range:
$0.40 - $0.49
52-week range:
$0.35 - $320.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.07
P/B ratio:
0%

Volume:
70.4K
Avg. volume:
62.8K
1-year change:
-99.87%
Market cap:
$2.1M
Revenue:
$0
EPS:
$-616.29

How Much Does Panbela Therapeutics Make?

Data Unavailable

Is Panbela Therapeutics Growing As A Company?

Data Unavailable

Panbela Therapeutics Stock Price Performance

What Is Panbela Therapeutics 52-Week High & Low?

Panbela Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Panbela Therapeutics?

Is Panbela Therapeutics Cash Flow Positive?

  • What Is PBLA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$25.2M
  • What Is Panbela Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $26.1M
  • What Is Panbela Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Panbela Therapeutics Return On Invested Capital

Data Unavailable

Panbela Therapeutics Earnings Date & Stock Price

Panbela Therapeutics Competitors

Panbela Therapeutics Dividend Yield

Data Unavailable

Panbela Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 69.63%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 25.00
Upside from Last Price: 5643.17%

Major Shareholders

  • How many PBLA shares are owned by institutional investors?
    354.8K PBLA shares are owned by institutional investors
  • How many PBLA shares are owned by insiders?
    1.5M PBLA shares are owned by insiders